May 2011 - Class Action Blog Archive
Uponor Pex plumbing fittings, specifically the F1960 fitting, have been causing problems for a number of consumers, which is leading to a potential Uponor class action lawsuit. Many consumers cite low water pressure as one of the major issues cause by the defective plumbing fixtures, as well as premature failure of the fittings, sometimes within a matter of months after installation.
In late 2010, some pharmacies allegedly began distributing Neurpath-B as a generic substitute. However, the “generic” drug uses a different source of folate than the active compound found in Metanx, and according to the open letter Pamlab, the manufacturer of Metanx, an examination of Neurpath-B has revealed that the product is not therapeutically equivalent.
The FDA announced on May 19, 2011 that it will be banning the sale of Diabetes drug, Avandia, in US pharmacies due to the severe cardiac risks it poses.
A study published in the New England Journal of Medicine discovered that women taking Zoloft while pregnant were twice as likely to have a child with a birth defect or complication as other women who took a different class of antidepressants.
A 2010 study of 108 patients with Zimmer NexGen CR-Flex knee replacements found that the device had a failure rate of 9.3%, while 36% of patients fitted with the Zimmer knee replacement experienced significant loosening of the device.
A recently released study offers new insight into the effectiveness of transvaginal mesh systems used to treat pelvic organ prolapse (POP). The study drew on research conducted on vaginal mesh surgery and its efficacy. While some studies of the vaginal mesh found it to be effective in treating pelvic organ prolapse, the current study noted that the safety and longevity of trans vaginal mesh surgery still needs to be demonstrated
A new study found that patients being treated with antidepressants may still experience symptoms of depression. The study, which was published in an April issue of the Journal of Clinical Psychopharmacology, found that 75% of selective serotonin reuptake inhibitor (SSRI) users still battled depression symptoms which should have been alleviated by the medication. Insomnia, sadness and an inability to concentrate were among the symptoms still suffered by SSRI patients, according to the study.